Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.730
+0.030 (0.81%)
At close: May 12, 2025, 4:00 PM
3.826
+0.096 (2.57%)
After-hours: May 12, 2025, 6:54 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $225.80 million as of May 12, 2025. Its market cap has increased by 97.20% in one year.
Market Cap
225.80M
Enterprise Value
123.62M
1-Year Change
97.20%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $225.80M, an increase of 35.21%. That is a compound annual growth rate of 6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 224.00M | -21.10% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |